Top Markets
#1 Siren Siren +39.19%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#3 Ocean Protocol Ocean Protocol +17.20%
#4 KUB Coin KUB Coin +14.89%
#5 Audiera Audiera +11.92%
#6 Perle Perle +10.80%
#7 Arowana Arowana +9.87%
#8 Geodnet Geodnet +9.30%
#9 Nockchain Nockchain +9.22%
#10 Wiki Cat Wiki Cat +8.40%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Rangering i aksjer #32158
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Aksjekurs
$0.05504527
Sist synkronisert: 2026-08-17
Markedsverdi
$10.89M
Endring (1 dag)
15.38%
Endring (1 år)
-10.64%
Land
CA
Handel Hemostemix Inc. (HEM)

Kategori

Healthcare
Utbytteavkastning for Hemostemix Inc. (HEM)
Hemostemix Inc. (aksjesymbol: HEM) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Hemostemix Inc. (HEM) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR